The National Institute for Health and Care Excellence (NICE) has approved vamorolone (Agamree, Santhera) as a treatment option for Duchenne muscular dystrophy (DMD) following a revised pricing deal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results